Document is current

Any future updates will be listed below

Receptor Activator of Nuclear Transcription Factor NF-κB (RANK), Its Ligand RANKL, and Natural Inhibitor of RANKL Osteoprotegerin (OPG) in the Blood Serum of Patients with Primary Bone Tumors

Crossref DOI link: https://doi.org/10.1007/s10517-017-3832-9

Published Online: 2017-08-29

Published Print: 2017-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark